PQ 21
21. Deputy Aengus Ó Snodaigh asked the Taoiseach and Minister for Defence if the attention of his Department or the Defence Forces medical authorities were advised when deciding to allow melfoquine as the anti-malaria drug of first choice for Defence Forces personnel on overseas missions in sub-Saharan Africa in particular in view of an article (details supplied) highlighting the World Health Organisation warning in 1989 that it could cause severe mental disturbances and psychiatric or neurological side effects. [3714/20]
Introduced
5 March 2020
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
5 March 2020
Summary
21. Deputy Aengus Ó Snodaigh asked the Taoiseach and Minister for Defence if the attention of his Department or the Defence Forces medical authorities were advised when deciding to allow melfoquine as the anti-malaria drug of first choice for Defence Forces personnel on overseas missions in sub-Saharan Africa in particular in view of an article (details supplied) highlighting the World Health Organisation warning in 1989 that it could cause severe mental disturbances and psychiatric or neurological side effects. [3714/20]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Defence Forces Medicinal Products
Defence Forces Medicinal Products
xml · EN · 5 March 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2020-03-05/21/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2020-03-05/pq_21